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Experimental Protocols 
Cell Maintenance 
Rat-1 fibroblasts cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen) 
supplemented with 10% (v/v) fetal bovine serum, 50 U/mL penicillin, and 50 µg/mL streptomycin. Cells were 
maintained in a 37 °C, 5% CO2 humidified incubator chamber. Near-confluent cells were passaged with 0.05% 
trypsin in 0.52 mM EDTA. 
Preparation of Cells for Fluorescence Microscopy 
Lab-Tek chambered coverglass slides (8-well, Nalge Nunc International) were prepared by treatment with 
fibronectin solution (10 µg/mL). The wells were rinsed twice with PBS, blocked with a 2 mg/mL solution of heat-
inactivated BSA at room temperature, and rinsed with PBS. 
Near-confluent cells in 100 mm Petri dishes were rinsed twice with warm phosphate-buffered saline (PBS). 
Cells were detached with trypsin in EDTA and added to the appropriate media. The cells were pelleted via 
centrifugation (200 g, 3 min) and counted. Cells were added at a density of 1 x 104 cells per well to prepared slides. 
Cells were grown in media overnight. 
After growth overnight in DMEM++, each well was washed twice (200 µL) with warm PBS. Cells were 
incubated for 5 min in serum-free medium lacking Met [SFM: DMEM, with 1 mg/mL bovine serum albumin (BSA, 
fraction V, Sigma-Aldrich), with 2 mM Glutamax I (Invitrogen), without Met], followed by 30 min in fresh SFM to 
deplete intracellular Met stores. Anisomycin (40 µM, Sigma-Aldrich) was added to cells during this time to inhibit 
protein synthesis. After incubation, either 1 mM Met or 1 mM Aha was added to the medium. After 4 h, wells were 
rinsed twice with DMEM++ before adding the dye-labeling mixture. 
Cells were exposed to coumarin-cyclooctyne in the labeling media DMEM-Imaging [DMEM lacking 
phenol red, with HEPES (Invitrogen), supplemented with 10% FBS and 1 mg/mL BSA]. Each coumarin-cyclooctyne 
was added to the labeling medium as a dilution from a 10 mM stock solution in DMSO. Labeling was allowed to 
proceed 10 min at 37 °C in the incubator chamber. After labeling, cells were washed twice before counterstaining. 
Cells were counterstained for 10 min with 300 nM MitoTracker Red CMXRos (Invitrogen). After treatment, cells 
were washed thrice with DMEM-Imaging and then imaged in DMEM-Imaging. Cells were kept in an incubator until 
they could be imaged (up to 3 h). 
For counterstaining with propidium iodide, cells were washed twice with DMEM++ before the addition of a 
1:1000 dilution of propidium iodide (1.0 mg/mL; Invitrogen) in DMEM-Imaging for 10 min. Cells were washed 
thrice before imaging. Fixed (3.7% paraformaldehyde, 10 min) and permeabilized (0.1% Triton X-100 in PBS, 3 
min) cells were also imaged as a control. Fixed cells stained with propidium iodide were not treated with coumarin-
cyclooctyne. 
Live cells were imaged on a confocal microscope (Zeiss LSM 510 Meta NLO) at California Institute of 
Technology's Biological Imaging Center. A heated chamber was placed around the microscope to image the cells at 
~37 °C. MitoTracker Red or propidium iodide fluorescence was obtained by excitation at 543 nm with emission 
collected between 565 and 615 nm. Transmitted light images were also collected to differentiate individual cells. 
Coumarin fluorescence was obtained by twophoton excitation at 800 nm (Ti:sapphire laser) with emission collected 
between 376 and 494 nm. The set of images for each 
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dye was obtained with identical conditions to capture coumarin fluorescence.  Individual optical slices of coumarin 
fluorescence were collected at 0.5 μm intervals in order to create an extended focus image (i.e., projection).  Images were 
acquired with a Plan-Apochromat 63x/1.4 oil objective (Zeiss) and analyzed with Zeiss LSM and ImageJ1 software.   
For MitoTracker Red, propidium iodide, and coumarin images in Figures 1, S1, S2 and S7, the brightness and 
contrast were manually adjusted for the images corresponding to each dye using ImageJ Software.  Then, the minimum and 
maximum pixel values were applied to each image from samples treated with that dye.  Stacks of coumarin fluorescence 
images were made into a projection using ImageJ software.  A maximum intensity projection was created by taking the 
maximum value at each pixel along the z-axis of the image plane through a stack of ten 0.5 μm-thick slices.  Again, the 
brightness and contrast were manually adjusted and applied to each image in the set (Aha, Met, and Aha+anisomycin). 
 
Preparation of Cells for Flow Cytometry  
Pulse-labeling was performed directly in the 6-well tissue culture dishes in which cells were grown.  Each well was 
washed twice with warm PBS, followed by a 30 min incubation in SFM to deplete intracellular Met stores.  Cells were then 
exposed to 1 mM Aha or 1 mM Met for 4 h.  In addition to examining a 4 h pulse-length, we also examined 0.8, 0.25, 0.5, and 
1 h pulses. Then, cells were washed twice with PBS.  Coumarin-cyclooctyne dye in DMEM-Imaging was added to each well 
for coumarin-labeling.  Dye concentrations of 0.5 μM to 50 μM were examined.  To examine alternative dye-labeling times, 10 
μM dye was added for 6-60 min in DMEM-Imaging.  After labeling, cells were washed twice with warm PBS and detached 
using 250 μL of 0.05% trypsin in EDTA.  Cells were added to 750 μL DMEM++, and 100 μL FBS was added to the bottom of 
the Eppendorf tube to improve cell pelleting.  Cells were pelleted by centrifugation (200g, 3 min) and washed once with 1 mL 
DMEM-Imaging, again with a cushion of FBS added to the bottom of the tube.  Finally, cells were resuspended in 400 μL 
DMEM-Imaging before filtering through a 50 μm Nytex nylon mesh screen (Sefar).  Cells were stored on ice until analysis. 
 
Flow Cytometry 
Cells were analyzed on a FACSAria flow cytometer (BD Biosciences Immunocytometry Systems) at Caltech’s Flow 
Cytometry Facility.  Coumarin fluorescence was excited by a 407 nm laser and detected after passage through a 450/40 
bandpass filter.  Forward- and side-scatter properties were used to exclude doublets, dead cells, and debris from analysis.  7-
aminoactinomycin D (7-AAD; Beckman Coulter) was used to exclude dead cells from analysis.  7-AAD was excited by a 488 
nm laser and detected after passage through a 695/40 filter.  Unlabeled cells, 7-AAD labeled cells, and coumarin labeled cells 
were analyzed to ensure minimal cross-over fluorescence in each channel.  When necessary, compensation was applied to 
reduce cross-over fluorescence.  Data was analyzed using FloJo7 software (Tree Star).   
 
Synthesis of Coumarin-Cyclooctyne Dyes  
All chemicals were purchased from Aldrich and used as received unless otherwise noted.  Dry solvents were obtained 
from commercial suppliers and used as received. Silica chromatography was performed using 230-400 mesh silica gel 60 
(EMD).  TLC was performed using Baker-flex silica gel IB-F plates; Rf values are reported under the same solvent conditions 
as those used for chromatography unless otherwise noted.  TLC plates were examined under UV light for fluorescent 
compounds or alternatively stained with KMnO4, ceric ammonium molybdenate, or p-anisaldehyde.  NMR spectra were 
recorded on Varian spectrometers (300 MHz for 1H) and processed with NUTS NMR software. NMR spectra were referenced 
to internal standards; proton and carbon spectra were referenced to tetramethylsilane. Fluorine spectra were referenced to 
hexafluorobenzene. All coupling constants are reported in hertz. FAB mass spectrometry was performed at the California 
Institute of Technology Mass Spectrometry Facility.  
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 1-Boc-amino-13-amino-4,7,10-trioxotridecane, 8.  A solution of ditertbutyldicarbonate (5.0 g, 23 
mmol) in 100 mL of CH2Cl2 was added via a dropping funnel to a rapidly stirred solution of 1,13-
diamino-4,7,10-trioxotridecane (10.1 g, 46 mmol) in 200 mL CH2Cl2 over a period of ~1 h.  The 
resulting clear solution was stirred 16 h then transferred to a separatory funnel and washed twice with 
100 mL of 0.1 M HCl and the aqueous layer was back-extracted 5 times with 50 mL of CH2Cl2.  The 
combined organics were dried over NaSO4 and evaporated to give 6.6 g (90%) of an opaque viscous oil, 
which was used without further purification.  1H NMR (300 MHz, CDCl3) δ 1.44 (s, 9 H), 1.55 (br s, 
2H), 1.68-1.84 (m, 4H), 2.81 (t, 2H, J = 6.8), 3.23 (br q, 2H, J = 6.2), 3.51-3.72 (m, 12H), 5.02-5.29 
(2x br t, rotomers, 1H); 13C NMR (75 MHz, CDCl3) δ 28.46, 29.61, 33.26, 38.48, 39.62, 69.47, 69.56, 70.18, 70.22, 70.58, 
70.60, 78.80, 156.05, 156.10; FAB MS calc for C15H33N2O5 (M+H)+ 321.2389, observed 321.2386. 
 
Boc-Linker-Coumarin 9. To a solution of 1-Boc-amino-13-amino-4,7,10-trioxotridecane, 8, 
(0.027g, 80 μmol) and triethylamine (0.015 g, 140 μmol) in 2 mL of CH2Cl2 in a foil-wrapped flask 
was added 7-dimethylaminocoumarin-4-acetic acid succinimidyl ester (0.025 g, 73 μmol, Anaspec) 
in 1 mL of CH2Cl2. The reaction was stirred for 12 h and then the solvent was removed and the 
product purified by silica chromatography (1:19 ethanol:ethyl acetate, Rf = 0.25) yielding 40 mg 
~100%. 1H NMR (300 MHz, CDCl3) δ 1.43 (s, 9 H), 1.73 (app quintet, 4 H, J = 6.2), 3.06 (s, 6 H), 
3.19 (br q, 2 H, J = 6.3), 3.36 (q, 2 H, J = 6.0), 3.45-3.65 (m, 14 H), 5.01 (br, t, 1 H), 6.07 (s, 1 H), 
6.50 (d, 1 H, J = 2.8), 6.62 (dd, 1 H, J = 2.5, 9.0), 6.75 (br t, 1 H), 7.53 (d 1 H, J = 9.0 ); 13C NMR 
(75 MHz, CDCl3) δ 28.44, 28.61, 29.66, 38.52, 40.12, 40.62, 69.42, 70.02, 70.08, 70.14, 70.24, 70.39, 78.89, 98.14, 108.50, 
109.13, 110.24, 125.84, 150.18, 153.04, 155.98, 161.86, 168.01; FAB MS calc for C28H43N3O8 (M+H)+ 549.3050, observed 
549.3027. 
 
1. Cyclooctyne acid 5 (0.0245 g, 0.095 mmol) was dissolved in 2 mL of DMF in a foil 
wrapped flask and placed under argon.  Pyridine (18 µL, 0.11 mmol) was added, and the 
solution was cooled in an ice bath. Pentafluorophenyl trifluoroacetate (18 µl, 0.11 mmol) was 
added, and the solution was stirred for 2 h.  The solvent was diluted with ethyl acetate (20 
mL), extracted twice with 1 M HCl, extracted once with saturated NaHCO3, dried over 
Na2SO4, and evaporated to give a clear oil that was resuspended in 2 ml of CH2Cl2.  This 
solution was added to a solution of 9 (0.043 g, 0.072 mmol) that had been deprotected by 
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treatment with 1:1 TFA:CH2Cl2 for 2 h, followed by solvent removal and resuspension in 2 mL CH2Cl2 and 22 µl (0.160 
mmol) triethylamine.  The combined solution was stirred under argon and monitored by TLC.  After 6 h, the reaction mixture 
was applied directly to a silica column and eluted with 2:9:9 ethanol:CH2Cl2:ethyl acetate (Rf = 0.24 in 1:19 ethanol:CH2Cl2) to 
give 0.044 g (0.064 mmol, 88%) of a yellow-white solid.  1H NMR (300 MHz, CDCl3) δ 1.46 (m, 1 H), 1.59-1.76 (m, 4 H), 
1.79-1.93 (m, 5 H), 1.93-2.39 (m, 4 H), 3.04 (s, 6 H), 3.27  (app q, 2 H, J = 5.9), 3.41-3.47 (m, 4 H), 3.51-3.66 (m, 12 H), 4.22 
(m, 1 H), 4.16 (d, 1 H, J = 12.5), 4.69 (d, 1 H, J = 12.5), 6.06 (s, 1 H), 6.46 (d, 1 H, J = 2.4), 6.59 (dd, 1 H, J = 9.1, 2.5), 6.79 
(br t, 1 H), 7.27 (br t, 1 H), 7.38 (d, 2 H, J = 8.1), 7.49 (d, 1 H, J = 9.1), 7.77 (d, 2 H, J = 8.1);13C NMR (75 MHz, CDCl3) δ 
20.70, 26.37, 28.53, 28.85, 29.72, 34.30, 38.63, 38.89, 40.09, 40.49, 42.32, 53.46, 69.92, 70.06, 70.17, 70.28, 70.42, 70.46, 
72.04, 92.50, 98.04, 100.66, 108.38, 109.20, 110.06, 125.76, 127.11, 127.70, 133.53, 141.81, 150.19, 153.07, 155.94, 162.12, 
167.58, 168.39; FAB MS calculated for C39H51N3O8 (M+H)+  690.3754, observed 690.3720. 
 
2. Cyclooctyne acid 6 (0.005 g, 0.019 mmol) was dissolved in 0.2 mL of DMF in a foil 
wrapped flask and placed under argon. Pyridine (6 µL, 0.08 mmol) was added, and the 
solution was cooled in an ice bath. Pentafluorophenyl trifluoroacetate (4 µL, 0.02 mmol) was 
added, and the solution was stirred for 3 h.  The solvent was diluted with ethyl acetate (20 
mL), extracted twice with 1 M HCl, extracted once with saturated NaHCO3, dried over 
Na2SO4, and evaporated to give a clear oil that was resuspended in 2 mL of CH2Cl2.  This 
solution was added to a solution of 9 (0.020 g, 0.04 mmol) that had been deprotected by 
treatment with 2 mL of 1:1 TFA:CH2Cl2 for 2 h, followed by solvent removal and 
resuspension in 2 mL CH2Cl2 and 22 µL (0.160 mmol) triethylamine.  The combined solution was stirred under argon and 
monitored by TLC.  After 8 h the reaction mixture was applied directly to a silica column and eluted with 1:19 ethanol:CH2Cl2 
(Rf = 0.24) to give 0.006 g (0.009 mmol, 45%) of oily yellow product.  1H NMR (300 MHz, CDCl3) δ δ 1.29-1.45 (m, 1H), 
1.60-1.76 (m, 4 H), 1.77-2.10 (m, 6 H), 2.13-2.36 (m, 3 H), 3.03 (s, 1 H), 3.04 (s, 6H) 3.07 (d, 1H),  3.25-.3.37 (app q, 2 H), 
3.38-3.46 (m, 4 H), 3.52-3.68 (m, 12 H), 6.06 (s, 1 H), 6.49 (d, 1 H, J = 2.5), 6.60 (dd, 1 H, J = 2.5, 9.0), 6.64 (br t, 1 H), 7.16 
(br t, 1H), 7.34 (d, 2 H, J = 7.9), 7.51 (d, 1H, J = 9.0), 7.74 (d, 2 H, J = 8.4); FAB MS calculated for C39H51N3O7F (M+H)+  
692.3711, observed 692.3726. 
 
3. Cyclooctyne acid 7 (0.0028 g, 0.014 mmol) was dissolved in 200 mL of CH2Cl2 in a foil-
wrapped flask and placed under argon. Triethylamine (8 µL, 0.06 mmol) was added, and the 
solution was cooled in an ice bath. Pentafluorophenyl trifluoroacetate (3 µL, 0.02 mmol) was 
added, and the solution was stirred for 1 h.  The solvent was removed under reduced pressure, 
and the resulting oil was resuspended in 3 mL of 1:1 ethyl acetate: hexane and passed 
through a short plug of silica (in a pasteur pipette). The solvent was removed under reduced 
pressure, and the material was resuspended in 1 mL of CH2Cl2.  This solution was added to a 
solution of 9 (0.0125 g, 0.023 mmol) that had been deprotected by treatment with 1.5 mL of 
1:1 TFA:CH2Cl2 for 2 h, followed by solvent removal, azeotropic removal of TFA with toluene and resuspension in 0.2 mL 
CH2Cl2 and 30 µL (0.21 mmol) triethylamine.  The combined solution was stirred under argon and monitored by TLC.  After 3 
h the reaction mixture was applied directly to a silica column and eluted with 1:19 ethanol:CH2Cl2 (Rf = 0.22) to give 5.3 mg 
(0.0082 mmol, 64%) of a yellow glassy solid.  1H NMR (300 MHz, CDCl3) δ 1.68-1.87 (m, 4H), 1.98-2.08 (m, 2H), 2.13-2.31 
(m, 3H), 2.39-2.63 (m, 3H), 3.06 (s, 6H), 3.31-3.45 (m, 4H), 3.45-3.69 (m, 15H), 3.92 (s, 2H), 6.07 (s, 1H), 6.48 (d, 1H, J = 
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2.6), 6.61 (dd, 1H, J = 2.9, 8.8), 6.79 (br t, 1H), 6.98 (br t, 1H), 7.51 (d, 2H, J = 9.3); FAB MS calculated for C33H46N3O8F2 
(M+H)+ 650.3253, observed 650.3233.  
 
Caco-2 Permeability Analysis 
 Each of the three coumarin cyclooctynes 1-3 was submitted to Apredica (Watertown, MA) for Caco-2 (human colon 
carcinoma cell) permeability analysis.  Each probe was supplied as a 10 mM stock solution in DMSO.  A test concentration of 
10 μM probe was applied to the apical side of a monolayer of differentiated Caco-2 cells.  Each probe was applied in transport 
buffer (1.98 g/L glucose in 10 mM HEPES, 1x Hank’s Balanced Salt Solution, pH 6.5) supplemented with 100 μM of the 
impermeable dye Lucifer Yellow.  For comparison, low permeability controls (Ranitidine, Vinblastine), Quinidine, and a high 
permeability control (Warfarin) were also applied to the cells. After 2 h, the 
amount of permeation for each probe was determined by LC/MS/MS analysis of 
the transport buffer removed from the basolateral side of the monolayer.  The value 
obtained is the permeability of each compound (Papp), which is defined as:        
Papp  =     dQ/dt 
     C0A 
where dQ/dt is the rate of permeation, C0 is the initial concentration of the test 
agent, and A is the area of the monolayer.   The Papp value for 1-3 and the standards 
are given in Table S1.  From the Papp values, we can conclude that each of the 
probes is membrane permeable and able to pass through the Caco-2 monolayer, 
although the assay also predicts that the bioavailability would be low.   
 
Fractionation of Proteins from Live Cells 
Pulse-labeling was performed directly in the 10 cm tissue culture dishes in which cells were grown.  Each plate was 
washed twice with warm PBS and incubated 30 min in SFM to deplete intracellular Met stores.  Anisomycin (40 μM) was 
added at this time.  Cells were exposed to 1 mM Aha, 1 mM Aha with anisomycin, or 1 mM Met for pulse-labeling (4 h).  
Then plates were washed twice with warm PBS.  Coumarin-cyclooctyne dyes  (10 μM) in DMEM++ was added to each plate 
for fluorophore-labeling.  After labeling for 30 min, cells were washed twice with warm PBS and detached using 0.05% 
trypsin in 0.52 mM EDTA.  Plates were scraped using a cell scraper and cells were collected and added to 4 mL DMEM++.  
Cells were pelleted by centrifugation (500 g, 10 min) and washed once with ice-cold PBS.  Cells were transferred to a clean 
eppendorf tube and fractionated using the QProteome cell compartment kit (Qiagen).  Each cell pellet was gently resuspended 
in 1 mL ice-cold extraction buffer CE1 and incubated at 4°C in a lab rotator for 10 min.  The lysates were centrifuged at 1000 
g for 10 min at 4°C.  The supernatants (fraction 1, F1) were carefully collected and stored on ice; this fraction contains 
primarily cytoplasmic proteins.  The pellets were then resuspended in ice-cold 1 mL extraction buffer CE2 and incubated at 
4°C in a lab rotator for 30 min.  The suspensions were then centrifuged at 6000 g for 10 min at 4°C.  The supernatants (fraction 
2, F2) were carefully collected and stored on ice; this fraction contains primarily membrane proteins and proteins from the 
lumen of organelles.  The pellets were then treated with Benzonase nuclease for 15 min at room temperature.  Then 500 μL of 
ice-cold extraction buffer CE3 was added to each tube.  The tubes were incubated at 4°C in a lab rotator for 10 min.  The 
suspensions were then pelleted by centrifugation (6800 g, 4°C, 10 min).  The supernatants were carefully collected (fraction 3, 
F3); this fraction primarily contains nuclear proteins.  The pelleted material was resuspended in 100 μL of room temperature 
buffer CE4 (fraction 4, F4); this final fraction contains the remaining proteins, most of which are cytoskeletal.  Fractionated 
Table S1: Caco-2 Permeability Assay 
Compound Mean apical Æ basolateral 
permeability:  Papp (10-6 cm s-1) 
Ranitidine 0.8 
Warfarin 48.4 
Quinidine 7.4 
Vinblastine 0.7 
1 3.2 
2 0.8 
3 0.7 
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proteins were precipitated in ice-cold acetone.  Pelleted protein was resuspended in RIPA buffer (Sigma) and the total amount 
of protein in each fraction was determined by BCA assay (Pierce).   
Protein samples isolated by the Qproteome kit were analyzed by western blot with antibodies appropriate for detecting 
proteins specific to different cellular fractions.  Detection of β-tubulin, a microtubule component found primarily in the 
cytoplasm3, was used to confirm that fraction 1 contained primarily cytosolic proteins.   Glucose regulated protein (GRP78), a 
membrane protein found in the endoplasmic reticulum4, was used to confirm that fraction 2 contained primarily membrane 
proteins and proteins from the lumen of organelles.  Fibrallarin, a nucleolar protein5, was used to confirm that fraction 3 
contained primarily nuclear proteins.  For western blot analysis, equal amounts of fractionated protein samples were separated 
on a 12% SDS-PAGE gel.  The gel was transferred to a nitrocellulose membrane (Hybond ECL, GE Healthcare) using a semi-
dry transfer system (Amersham Biosciences).  The membrane was blocked at room temperature for 1 h before incubation with 
primary antibodies for 2 h at room temperature [anti-GRP78 (BD Biosciences), 1:250 or anti-fibrillarin (Abcam), 1:1000].  
Washed membranes were then probed with a secondary antibody, goat anti-mouse IgG-HRP conjugated (Chemicon, 1:10000).   
HRP activity was detected on a Typhoon molecular imager (GE Healthcare) following incubation with reagents from the 
ECL+ kit (GE Healthcare).  For β-tubulin detection, the blot was incubated with anti-β-tubulin-HRP antibody (Abcam, 1:1000).   
Representative western blots of fractionated protein samples are shown in Figure S3. 
 Fluorescence from each fraction was measured on a Safire II fluorescence plate reader (Tecan).  Raw fluorescence data 
were normalized either by cell number (Table S2) or by total amount of protein (Table S3) to yield the percentage of total 
fluorescence associated with each fraction.   
 
F1 F2 F3 F4 
1 25.5± 0.8% 61.0± 2.7% 6.7± 1.7% 6.8± 0.1% 
2 25.4± 2.4% 63.6± 1.1% 5.4± 2.3% 5.6± 0.9% 
3 40.0± 3.4% 38.5± 2.6% 11.7± 1.3% 10.0± 0.5% 
Table S2.  Percent fluorescence normalized by cell number in Aha treated samples.  F1, fraction F1, is primarily cytosolic 
proteins.  F2 is primarily membrane proteins and proteins from the lumen of organelles.  F3 is primarily nuclear proteins, while 
F4 is the insoluble fraction, which contains primarily cytoskeletal proteins.   
 
 F1 F2 F3 F4 
1 13.7± 0.8% 55.8± 2.7% 11.3± 2.9% 19.2± 0.7% 
2 15.1± 1.1% 58.1± 3.0% 9.6± 4.3% 17.2± 0.2% 
3 21.4± 1.4% 36.5± 0.5% 19.0± 1.6% 23.1± 0.7% 
Table S3.  Percent fluorescence normalized by protein concentration in Aha treated samples.  F1, fraction F1, is primarily 
cytosolic proteins.  F2 is primarily membrane proteins and proteins from the lumen of organelles.  F3 is primarily nuclear 
proteins, while F4 is the insoluble fraction, which contains primarily cytoskeletal proteins.   
 
 
In Vitro Reactions  
 Model reactions between 1 μM 3 and 1 mM amino acid were performed in PBS (pH 7.4).  Reactions proceeded at 37 °C 
until analysis.  Liquid chromatography was performed on a Waters HPLC system with a Microsorb C18 column (Varian)  The 
buffers used for separation of the reaction components were 0.1% trifluoroacetic acid in water (Eluent A) and 100% 
Acetonitrile (Eluent B).  The gradient was 0-2 min, 100% A; 2-4 min, 100-70% A; 4-14 min, 70-40% A; 14-28 min, 40-0% A.  
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Dual detection at 280 and 350 nm was used to identify the substrate and product peaks, which were collected for analysis by 
electrospray ionization mass spectrometry at California Institute of Technology’s Mass Spectrometry Facility6.  The peak 
corresponding to unreacted 3 was confirmed [calculated C33H46N3O8F2 (M+H)+ 650.33, observed 650.1].  The peak 
corresponding to the Aha-product was collected and confirmed [calculated C37H53F2N7O10 (M+H)+ 794.38, observed 794.3].  
No product was observed for reactions of 3 with Met after 24 h.   
The reaction of 3 with Cys resulted in a complex mixture of products that could not be characterized by electrospray mass 
spectrometry.   Instead, the overnight reaction of 3 (50 μM) with Cys (1 mM) or glutathione (1 mM) was characterized by 
tandem mass spectrometry.  The reaction mixture was subjected to reversed-phase capillary chromatography with an Agilent 
1200 LC system using a 100-μm X 1-cm (5-μm, 100 Å Magic C18 resin; Michrom Bioresources) fritted capillary precolumn 
(Integrafit, New Objective) and a 100-μm X 10-cm self-packed C18 column (5-μm, 100 Å Magic C18 resin; Michrom 
Bioresources).  A flow rate of 500 nl/min was accomplished through a splitter.  The components were separated with a 
gradient between solvent A (0.1% formic acid) and solvent B (ACN, 0.1% formic acid). The gradient was from 2% up to 60% 
solvent B within 30 min. The species were identified by CID (collision induced dissociation) on a Thermo-Finnigan LTQ ion 
trap mass spectrometer. Six dependent scans followed each survey scan.  Data were searched manually and tandem mass 
spectra peaks assigned, as shown in Figure S6. 
The data from the HPLC analysis were fitted to a single-exponential decay function using Origin software (OriginLab).  
The peak area (y) for 3 over time (t) was fitted to the equation:  
y = yo + Ae(-t/τ) 
The time constant (τ) was converted to the half-life (t1/2) using the equation: 
t1/2 = τln(2) 
Four experiments were averaged to obtain the half-life for Aha (16 ± 3 min) and Cys (27 ± 5 min).   
The model reactions of Aha, Cys, and Met with coumarins 1 and 2 were also examined.  The reaction mixtures 
contained 5 μM 1 or 2 with 1 mM amino acid in PBS (pH 7.4).  Reactions proceeded at 37 °C until analysis by HPLC as 
described above.  Both 1 and 2 reacted with Aha, but did not form a product with Cys or Met after 24 h.  The replacement of 
the fluorine on 2 with a hydroxyl occurred under the reaction conditions, as previously reported2a. 
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Supporting Data: 
 
Aha                 Aha+Aniso Met
Aha                 Aha+Aniso Met
Aha                 Aha+Aniso Met
3
1 2
 
Figure S1.  Projections of coumarin fluorescence from labeled proteins in Rat-1 Fibroblasts.  The coumarin projections 
correspond to the single slice coumarin images shown in Figure 1.  Single slice images of the mitochondria are included to 
distinguish individual cells and the cytoplasmic space and to ensure correct mitochondrial morphology.  The scale bar 
represents 20 μm.   
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A)
B)
C)
Individual Z-Slices                                          Projection
 
Figure S2.  Individual optical slices of coumarin fluorescence acquired using confocal microscopy and two-photon excitation.  
Slices were collected at 0.5 μm intervals in order to create an extended focus image (i.e., projection) shown on the right.  Cells 
were dye-labeled with fluorophores 1 (a), 2 (b), or 3 (c) as described in Figure 1.   
 
 
Figure S3.  Western blot detection of specific marker proteins found within SDS-PAGE separated proteins from isolated 
cellular fractions.  For each lane, 5 µg of total proteins was loaded. Top: β-tubulin, a microtubule protein residing primarily in 
the cytosol, was detected in fraction 1 (F1) samples.  Middle: Glucose regulated protein (GRP78), a membrane protein residing 
within the endoplasmic reticulum, was detected in fraction 2 (F2).  Bottom: Fibrillarin, a nucleolar marker protein, was 
detected in fractions 3 and 4.   
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Figure S4.  Flow cytometric analysis of pulse-labeling length and dye-labeling length.  A.  Mean fluorescence enhancement of 
cells pulse-labeled for 0.5, 1, or 4 h.  Cells were dye-labeled with 10 μM 3 or 50 μM 2 for 10 min before analysis.  B.  Mean 
fluorescence enhancement of cells labeled with 10 μM 1, 2 or 3 for different times after a 4 h pulse.  For each sample, 30,000 
events were collected.   
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Figure S5.  Chromatograms of the in vitro reaction of 3 with Aha or Cys.   Reaction mixtures contained 1 μM 3 with 1 mM 
Aha (A) or 1 mM Cys (B) in PBS (pH 7.4).  The reactions proceeded at 37 °C until analysis by HPLC.  Detection at 350 nm 
was used to observe changes in the starting material (3: 18.5-19 min) and product peaks (Aha: 15-16 min, Cys: 14-17 min) at 
different time points.   
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Figure S6.  Tandem mass spectrum of compound 3 reacted with A) cysteine or B) glutathione.  An asterisk denotes a peak 
found for the corresponding bond cleavages shown. 
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Figure S7.  Viability of cells dye-labeled with coumarin-cyclooctynes.  Cells were pulse-labeled 4 h in media supplemented 
with 1 mM Met or 1 mM Aha.  Cells were dye-labeled 10 min with 50 μM 1, 50 μM 2, or 10 μM 3.  Cells were washed, 
treated with 1 μg/mL propidium iodide for 10 min, washed, and then imaged.  Fixed cells were treated with 3.7% 
paraformaldehyde for 10 min instead of staining with coumarin cyclooctyne.  After fixation, cells were permeabilized and 
stained with propidium iodide.  The scale bar represents 50 μm.   
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